Form 8-K - Current report:
SEC Accession No. 0001157523-21-000659
Filing Date
2021-05-13
Accepted
2021-05-13 16:02:24
Documents
2
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 EDGEWISE THERAPEUTICS, INC. 8-K a52428854.htm 8-K 23962
2 EXHIBIT 99.1 a52428854ex99_1.htm EX-99.1 66491
  Complete submission text file 0001157523-21-000659.txt   91543
Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40236 | Film No.: 21919492
SIC: 2834 Pharmaceutical Preparations